Medicare Will Limit Coverage of Controversial $28,000/Year Alzheimer’s Drug; One Clinical Trial Patient Has Already Died

By B.N. Frank In July, the Food and Drug Administration (FDA) approved an Alzheimer’s drug that May not be safe or effective Would cost $56,000/year…

Medicare Will Limit Coverage of Controversial…

Go to Source
Author: Activist Post

0 0 votes
Article Rating

Comments

0 Comments
Inline Feedbacks
View all comments